Introduction {#section0005}
============

Macroautophagy (hereafter referred to as autophagy) is a tightly regulated and evolutionarily conserved mechanism for the sequestration, lysosomal degradation, and recycling of discrete intracellular portions of eukaryotic cells, facilitating the removal of materials not typically degraded by the ubiquitin--proteosomal pathway. Regulators of this process include hormones and growth factors that suppress autophagy during cellular growth, as well as intracellular levels of nutrients, oxygen, and energy, allowing the pathway to act as a defense mechanism against inducers of cellular stress ([@bib93], [@bib136], [@bib139]). Perturbations in autophagy have been correlated with numerous pathological conditions, including oncogenesis and cancer progression, neurodegenerative disorders, liver disease, myopathy, and cardiac disease, highlighting the importance of this pathway in human health and cellular homeostasis ([@bib63], [@bib72], [@bib77]). Autophagy has been shown to play an important role in the pathogenesis of several viral infections and is suggested to act as both an inducer and effector of innate and adaptive immune responses against intracellular pathogens, including viruses. Currently, evidence suggests that viruses have evolved a diverse array of countermeasures to contend with this pathway; some inhibit autophagy and are negatively affected when this interference is abrogated, while others appear to subvert it to their own ends and respond positively when it is induced. However, still other viruses are seemingly unaffected by autophagy, and do not appear to regulate the pathway through any apparent mechanism(s). This review seeks to provide both a synopsis of currently known and suspected viral interactions with the autophagy pathway, and to stimulate a critical discussion concerning the central trends that have been suggested within this field of research.

Overview of the mechanisms and regulation of autophagy {#section0010}
======================================================

For the sake of brevity, only an overview of the mechanisms and regulation of the autophagy mechanism will be provided. The reader is referred to more detailed reviews concerning specific aspects of autophagy, such as the formation and maturation of the autophagosome ([@bib68], [@bib76], [@bib83], [@bib100], [@bib137], [@bib139], [@bib143]), regulatory mechanisms of this pathway ([@bib71], [@bib93], [@bib136], [@bib139]), roles in innate antigen recognition and MHC antigen presentation ([@bib23], [@bib22], [@bib62], [@bib80], [@bib87], [@bib106], [@bib129]), and the relationship between autophagy and regulated cell death ([@bib19], [@bib33], [@bib52], [@bib69], [@bib102]). The core process of autophagy is the *de novo* synthesis of a double-membrane-bound vesicle capable of fusing with an endosome or lysosome, which ultimately leads to the catabolic degradation of the encapsulated cargo ([Fig. 1](#fig1){ref-type="fig"} ). In mammals, this process begins with the expansion of a small, flat membrane sac of uncertain origin (termed the isolation membrane or phagophore). As autophagy-related (Atg) proteins are recruited to its surface, this membrane sac elongates and curves until the ends merge to form a double-membrane-bound vesicle (autophagosome). Atg proteins are then recovered or disassociate from the autophagosome, and the completed structure fuses with an endosome (amphisome) or lysosome (autolysosome). A brief overview of mammalian genes of particular significance in the regulation and execution of autophagy is provided in [Table 1](#tbl1){ref-type="table"} .Fig. 1Overview of the autophagy process. In response to cellular stimuli such as starvation and immune signals, the class I PI(3)K (phosphoinositide 3-kinases)-induced Atg1 complex and a class III PI(3)K complex involving Beclin-1 activate downstream ATG proteins in a series of steps that guide the induction, elongation, maturation, and degradation of the autophagosome. Two ubiquitin-like conjugation systems involving Atg12 (a) and LC3 (b) direct the vesicle elongation of the isolation membrane, which forms a crescent shape to sequester the cytoplasmic cargo. Upon completion, the autophagosome then undergoes the maturation step through a series of remodeling processes including fusion with endosomes/lysosomes. Fusion with lysosome helps the autophagosome mature into an autolysosome in which the autophagic vacuole along with its content is degraded.Table 1Significant genes in the mammalian autophagy pathway.GeneImportant interactionsProtein function/characteristicsFormation of autophagosomes *ULK1 (ATG1)*Atg13, FIP200 (Atg17)Ser/Thr kinase activity important for function; target(s) unknown. Downstream of mTOR signaling. Potentially involved in Atg9 cycling. *Beclin-1 (ATG6)*hVps34, Bcl-2/Bcl-xL, UVRAGStructural regulator of class III PI3 kinase hVps34. Contains BH3-like domain that is down-regulatory when occupied. *hVPS34*Beclin-1, mTORClass III PI3 kinase; resulting PtdIns(3)Ps recruit Atg16L multimer/Atg18 to phagophore. Conflictingly activates mTor in response to amino acids. *ATG9*Atg2, Atg18Transmembrane protein. Transits between phagophores and trans-Golgi/late endosomes. Possible role(s) in protein recycling and/or membrane transit. *ATG12*Atg5, Atg16LCovalently bound to Atg5 via mechanism similar to ubquitination. *ATG7*LC3, Atg12Functionally similar to E1 ubiquitin activating enzyme (E1-like). Activates C-terminal glycine of both Atg12 and LC3. *ATG10*Atg12, Atg5Functionally similar to E2 ubiquitin conjugating enzyme (E2-like). Accepts activated Atg12 and conjugates to internal lysine of Atg5. *ATG5*Atg12, Atg16LCovalently bound to Atg12; conjugation allows Atg5 to associate with Atg16L. *ATG16L*Atg5--Atg12Associates with Atg12--Atg5 and dimerizes. Present on outer surface of expanding phagophore; aids membrane curvature and LC3 recruitment (E3-like). Recycled. *ATG4*LC3Cysteine protease; exposes C-terminal glycine on LC3 prior to lipidation. Subsequently recycles LC3 from outer membrane of autophagosome. *ATG3*LC3, Atg7Functionally similar to E2 ubiquitin conjugating enzyme (E2-like). Conjugates LC3 with phosphatidylethanolamine (PE) phospholipid. *MAP1LC3 (ATG8)*Atg4Experimental marker of induction. Cytosolic form (LC3-I) conjugated to PE, becoming membrane-associated (LC3-II). Possible role(s) in membrane expansion, autophagosome transit, and lysosomal fusion. Partially recycled by Atg4.Regulation of autophagy *PI3K* (class I)Produces PtdIns(3)p that activates the Akt/PKB-mTor pathway. *PTEN*Phosphatase that counteracts PI3K by dephosphorylating PtdIns(3)p. *AKT/PKB*PDK1, Tsc 2Ser/Thr kinase. Activated by PDK1 in the presence of PtdIns(3)p. Inactivates Tsc 2. *REDD1/REDD2*Transcriptionally up-regulated in response to hypoxia. Inactivates mTor pathway. *AMPK*LKB1, Tsc2Activates Tsc2, leading to the induction of autophagy when the AMP/ATP ratio is high. *TSC2*Tsc1, Rheb, Akt/PKB, AMPKGTPase-activating protein (GAP) with Tsc1; inactivates Rheb. Akt/PKB interferes with function, as does Erk1/2. AMPK enhances activity. *Rheb*Tsc1/Tsc2, mTorSmall GTPase. Activates mTor via binding kinase domain in GTP-dependent fashion. Tsc1/Tsc2 GAP activity converts to inactive, GDP-bound form. *mTOR*Rheb, raptor, mLST8Key regulator of cellular growth. Autophagy induced when mTor inactivated. Ser/Thr kinase. Forms two protein complexes; mTORC1 associated with autophagy. Anti-apoptotic Bcl-2 familyBeclin-1Inhibit autophagy via binding with BH3 motif on Beclin-1. JNK1-mediated phosphorylation disrupts interaction and associated inhibition. BH3-only Bcl-2 familyAnti-apoptotic Bcl-2 familyCompetitively bind with anti-apoptotic Bcl-2 family members, interfering with their association with Beclin-1. Stimulate autophagy. *JNK1*Anti-apoptotic Bcl-2 familyPhosphorylates anti-apoptotic Bcl-2 family members, inhibiting interaction with Beclin-1. Activity induces autophagy. *UVRAG*Bif-1, Beclin-1Interacts with Beclin-1\'s coiled-coil domain, strengthening Beclin-1/hVps34 interactions; promotes autophagy. Possible additional role in lysosome fusion. *p53*Controversial/contradictory role(s) in autophagy. P53-dependent autophagy observed experimentally. However, cytosolic p53 is inhibitory (mechanism unknown). *DRAM*Transmembrane lysosomal protein transcriptionally induced by p53. Stimulates autophagy. Necessary for both p53-dependent autophagy and apoptosis.

Central in the regulation of autophagy are two key proteins: mTOR and Beclin-1 ([@bib93], [@bib110], [@bib136]). mTOR, a conserved serine/threonine kinase, is a component of protein complexes that integrate cellular signals relating to growth factors, nutrient and energy status, and cellular stress ([@bib136]). Important activators of mTOR include the class I PI3K-Akt/PKB signaling pathway and high concentrations of specific amino acids; high AMP/ATP ratios and hypoxia inactivate this pathway ([@bib7], [@bib12], [@bib93], [@bib136]). Activated mTOR suppresses autophagy, enhancing the accumulation of cellular bulk by limiting lysosomal digestion. Downstream of mTOR, Beclin-1 is at the heart of a regulatory complex for the class III PI3K hVps34, whose activity is essential during autophagosome formation. Activators, such as UV radiation resistance associated gene (UVRAG), Bax-interacting factor-1 (Bif-1), and activating molecule in Beclin-1-regulated autophagy-1 (Ambra-1) associate with the Beclin-1 complex and enhance PtdIns(3)P production, while the Bcl-2 family anti-apoptotic proteins such as Bcl-2 and Bcl-xL bind to Beclin-1 and act in an inhibitory fashion ([@bib93], [@bib110]). The Bcl-2-related inhibition of autophagy is abrogated by stress-activated c-Jun N-terminal protein kinase 1 (JNK1) phosphorylation and competition from other BH3 binding domain-containing proteins, providing one of several direct mechanistic links between autophagy and apoptosis ([@bib110], [@bib131], [@bib132]).

Numerous other cellular factors have been shown or are hypothesized to regulate autophagy, many of which have importance in viral infections. The eukaryotic initiation factor-2 alpha (eIF2α) and the starvation-responsive general control nonderepressible-2 (GCN2) eIF2α kinase are both indispensable for starvation-induced autophagy, suggesting that other eIF2α kinases with important roles in antiviral defense, such as double-stranded RNA (dsRNA)-dependent protein kinase (PKR) and PKR-like ER kinase (PERK), may also up-regulate this pathway in response to cellular stressors ([@bib51], [@bib120], [@bib121]). Immune signaling molecules can modulate autophagy; type II interferon-γ (IFN-γ) and tumor-necrosis factor-α (TNF-α) are stimulatory, while the TH2-type cytokines interleukin-4 (IL-4) and IL-13 are suppressive ([@bib24], [@bib62]). Certain pathogen-associated molecular patterns (PAMPs) trigger autophagy through their cognate pattern recognition receptors (PRRs), including Toll-like receptor 3 (TLR3), TLR4, and TLR7, although the molecular mechanism(s), physiological function(s), and range of PRRs that induce this pathway are all areas of continuing research ([@bib23], [@bib22], [@bib87]). The p53 protein possesses a dual role in the regulation of autophagy dependent upon its localization; cytoplasmic p53 represses autophagy and must be degraded for autophagy to proceed, whereas nuclear p53 appears to induce it ([@bib70], [@bib124]). Many additional cellular factors, including extracellular signal-regulated kinase (Erk1/2) activation ([@bib91], [@bib109], [@bib130]), intracellular release of calcium ([@bib34], [@bib38]), increases in reactive oxygen species (ROS) ([@bib27], [@bib26], [@bib103], [@bib104]), and endoplasmic reticulum (ER) stress ([@bib25], [@bib51], [@bib84], [@bib142]) have also been shown to trigger the pathway to autophagy.

While numerous experimental approaches including electron microscopy, LC3 lipidation (aggregation and modification), and protein degradation studies, amongst others, can be employed to identify or quantify autophagy in higher eukaryotes, a few warnings should be considered regarding the specific challenges these methods present. First, as autophagy is a process with numerous components, steps, and phases, it is important to clarify whether a given assay measures a step within this pathway (such as LC3 lipidation) or its overall physiological consequence (the aim of protein degradation studies). Since several viruses have been shown to modulate autophagy at multiple stages with varying effects, it is often necessary to combine assays examining both induction and maturation in order to make accurate observations. Second, while autophagy is a responsive cellular process, capable of fluctuation, most assays capture this dynamic process at a single static moment in time. This can pose challenges, as cellular populations are frequently asynchronous and the effects of a viral infection may vary during the course of the cell cycle. Finally, as different cell types have been shown to display different autophagy responses, it can be difficult to make direct comparisons between different virus-cell systems. Particular caution should be used when studying viruses, like HIV-1, which infect more than one cell type. For further information regarding the limitations of current autophagy assays, readers are advised to consult excellent reviews on this subject ([@bib49], [@bib75]).

Viral interactions with the autophagy pathway {#section0015}
=============================================

Many viruses have been shown to evade, subvert, or exploit autophagy, seemingly to insure their own replication or survival advantage, while others are apparently unaffected by this intrinsic pathway and fail to modulate it by any detectable way. The following discussion concerning viral infection, autophagy, and host immunity has been structured on four emergent themes that have been identified in the research published to date; autophagy as 1) a mechanism for membrane remodeling, 2) a digestive defensive response, 3) a means of cellular surveillance, and 4) a cellular fate-determining process. A comprehensive summary of viruses for which studies have been undertaken is provided in [Table 2](#tbl2){ref-type="table"} .Table 2Brief summary of known interactions between autophagy and viral infections.VirusKnown interaction(s) with autophagyKey referencesAdenovirusContradictory results; autophagy may enhance or detract from engineered adenovirus-induced cell death; differences possibly cell-type/virus-specific.[@bib40], [@bib9]CoronavirusContradictory evidence. May induce or subvert autophagy membrane remodeling. Autophagy may enhance viral replication.[@bib94], [@bib146]CoxsackievirusAutophagosome formation enhances CVB3/CVB4 replication *in vitro*. Autophagy affects virally induced apoptosis.[@bib135], [@bib141]CytomegalovirusInhibits autophagy through unidentified mechanism.[@bib149]Dengue virusInduces autophagy. Disruption reduces corresponding viral titers. Membrane co-localization observed with serotype-specific differences.[@bib58], [@bib90], [@bib46]*Drosophila* C virusInduces formation of COPI-dependent vesicles. Interactions with autophagy mechanism unknown.[@bib150]Enterovirus 71Induces/co-localizes with autophagic membranes. Induction increases viral titer. Mechanism unclear.[@bib39]Epstein--Barr virusAutophagy may aid EBV MHC-II antigen presentation, but contradictory evidence exists. Possibly part of proliferation regulation.[@bib89], [@bib153]Hepatitis B virusEncodes transcriptional transactivator HBx, resulting in increased expression of Beclin-1. Sensitizes cells to autophagy signals.[@bib122]Hepatitis C virusInduces autophagy; inhibits maturation. Knockdown of autophagy genes or ER stress response limits replication. Autophagy may aid HCV antigen presentation/TLR detection in some cell types.[@bib112], [@bib28]Herpes simplex virus type IViral encoded ICP34.5 antagonizes pathway through inhibition of PKR/eIF2a induction, as well as Beclin-1 binding. Autophagy effects of minimal importance *in vitro*, but essential for neurovirulence *in vivo*.[@bib121], [@bib3], [@bib88]; [@bib151]Human immunodeficiency virusAutophagy-related mechanism part of envelope protein-induced bystander T cell death and HIV dementia. Pathway dysregulated in some infected cell types, but some components identified as necessary host co-factors.[@bib30], [@bib4], [@bib147], [@bib32], [@bib56]Influenza virusInduces autophagosome formation; inhibits maturation. Interference decreases viral yield. May enhance MHC-II antigen presentation.[@bib152], [@bib156]Kaposi\'s sarcoma-associated herpesvirusEncodes viral homolog of Bcl-2 that inhibits autophagy through binding interactions with Beclin-1\'s BH3 domain. Viral FLIP suppresses autophagy through inhibition of Atg3.[@bib92], [@bib53], [@bib59]ParvovirusInduces formation of autophagosome-like vesicles, possibly to extend host cell survival during viral replication process.[@bib82]PoliovirusInduces formation of double-membrane, LC3-positive vesicles. Aids viral replication and release. Viral 2BC protein triggers LC3 lipidation.[@bib42], [@bib125]RhinovirusDoes not induce or modulate autophagy. Replication unaffected by induction or inhibition of pathway.[@bib42], [@bib16]Sendai virusIn pDCs, autophagy enhances delivery of viral nucleic acids to endosomes for TLR7 recognition.[@bib57]Sindbis virus*In vivo* up-regulation of autophagy via Beclin-1 over-expression reduces fatal encephalitis in mice.[@bib66]Tobacco mosaic virusAutophagy necessary to restrict virally induced programmed cell death responses to the site of infection.[@bib67]Vaccinia virusInduces vesicle formation, but mechanism independent of autophagy.[@bib145]Varicella-zoster virusInduces autophagy. Role in infection unclear.[@bib155]Vesicular stomatitis virusAutophagy enhances endocytic detection in pDCs, but may diminish cytosolic detection/antiviral responses in other cell types.[@bib44], [@bib57]; [@bib154]

Autophagy is a mechanism for remodeling internal membranes associated with viral replication {#section0020}
--------------------------------------------------------------------------------------------

For many viruses, the production of progeny virion is intimately associated with host cell membranes or cytoskeletal elements. As such, many viruses are known to subvert host endosomal and secretory pathways in order to induce host membrane alterations that can then support viral replication and assembly ([@bib74]). A number of viruses have been shown to replicate in, or in close association with, multi-membraned vesicles that possess many of the characteristics of autophagosomes. Given the nature and location of these vacuoles, there is strong evidence that autophagosomes may serve as a site of viral replication during some infections and that the autophagy pathway might therefore be exploited by viruses to enhance virion production. Supporting this assertion, the membranes associated with viral replication are often derived from the ER, which has also been suggested as a source of the autophagic double-membrane ([@bib73]). Indeed, the similarities between autophagic vacuoles and some virally induced membrane alterations has lead to increased suspicion, and in some cases proof, of a connection between positive-stranded RNA viral replication and the autophagy mechanism.

A link between poliovirus (PV)-induced double-membrane vesicles and autophagy has long been suggested, and is often cited as the classic example of viral exploitation of the autophagy pathway. Ultrastructural and biochemical analyses have revealed that PV induces massive rearrangements in intracellular membranes, resulting in clusters of double-membrane-bound vesicles capable of supporting viral replication complexes ([@bib14], [@bib101], [@bib105], [@bib117]). These PV-induced vesicles display the classic autophagosomal marker LC3, which has been hypothesized to be directly recruited by viral proteins ([@bib42], [@bib125]). Subsequent studies have further shown that additional secretory vesicle trafficking molecules are also recruited during the formation of these membranous replicative vesicles ([@bib11]), and that the association of these vesicles with the microtubule network aids in the non-lytic release of PV virion particles ([@bib126]). Hence, it has been postulated that PV factors initiate elements of both the interrelated secretory trafficking and autophagy pathways to ultimately create a membranous structure capable of supporting both viral replication and virion egress. Besides PV, several other picornaviruses also appear to subvert the autophagy machinery to promote their replication. The group B Coxsackieviruses, CVB3 and CVB4, induce autophagosome formation, and biochemical inhibition of this pathway negatively impacts virion production ([@bib135], [@bib141]). Similarly, the enteropathogen EV71 has been shown to trigger autophagy *in vitro*, and that this induction can significantly increase viral yield ([@bib39]). Apart from the *Picornaviridae* family, two Dengue virus (DENV) serotypes (DENV-2 and DENV-3) have also been shown to interact with the autophagy machinery to promote their replication ([@bib46], [@bib58], [@bib90]). Interestingly, the stage of the autophagic process with which DENV is associated varies depending upon the viral serotype involved; DENV-2 translation/replication complex has been shown to specifically locate with pre-lysosomal fusion amphisomes, while DENV-3 requires further vesicle maturation and post-lysosomal fusion vacuoles (autolysosomes) to efficiently produce virions ([@bib46], [@bib90]). The autophagy pathway also appears to be critical in the replication of another *Flaviviridae* member, namely the hepatitis C virus (HCV), which has also been shown to induce autophagosome formation ([@bib1], [@bib28], [@bib112], [@bib123]). In the case of HCV, autophagy is thought to be responsible for providing membranous support structures during the initial translation and *de novo* replication of HCV RNA following infection, but subsequently contributes little to virus maturation once an infection is stably established in the host cell ([@bib28], [@bib123]). Finally, basal levels of autophagy have recently been shown to enhance macrophage-tropic human immunodeficiency virus (HIV) viral protein processing and virion production *in vitro*, suggesting a role for autophagy in HIV biosynthesis in this cell type ([@bib56]).

While these results are strongly suggestive that viruses can subvert or induce autophagy in order to create advantageous membrane alterations, other research has demonstrated that this effect is not universal. Not all viral infections that induce membrane alterations, including some which are closely related to the examples provided above, modulate or are affected by the autophagy pathway. The replication of human rhinovirus 2, a picornavirus that shares many similarities with PV, is not affected by drugs that either inhibit or induce autophagy, and does not elicit the formation of LC3-positive vesicles ([@bib16]). Contradictory observations have been made for the *Coronaviridae* members, murine hepatitis virus (MHV) and severe acute respiratory syndrome-coronavirus (SARS-CoV); some studies have suggested that endogenous LC3 co-localizes with SARS-CoV and MHV vacuole-associated replicase proteins ([@bib94], [@bib95]), yet other studies have had difficulty corroborating these results ([@bib21], [@bib113], [@bib116]). In line with these observations, MHV viral replication and release have been shown to be comparable in cells with both normal and defective autophagy mechanisms ([@bib146]). Likewise, the viral production kinetics of vaccinia virus, which has been shown to utilize double-membrane vesicles for its replication, was similar in wild-type, Atg5^−/−^, and Beclin-1-deficient cells ([@bib145]). Thus, subversion of autophagy as a mechanism for inducing membrane alterations may be either cell-type- or virus-dependent. These results suggest that considerable care should be exercised prior to concluding that autophagy is the mechanism responsible for membrane alterations observed under microscopy to ensure that they are biochemically and mechanistically connected to this pathway. While the evidence to date strongly indicates a positive role for autophagy in the replication of some viruses, the observed variation, particularly amongst closely related viruses, suggests that other mechanisms may exist for inducing similar alterations in host cells. One should approach these studies carefully with the correct diagnostic tools for autophagy.

Autophagy can be a mechanism for defense: the digestion or elimination of unwanted viral intruders {#section0025}
--------------------------------------------------------------------------------------------------

As the previous section has indicated, viruses may induce autophagy for their own replicative advantage; yet, the same process may also confine viral replication complexes within vesicles as an innate defense against infection ([@bib133]). Furthermore, autophagy has been documented to function as a host cell defense against some intracellular pathogens. This process, which has been termed xenophagy ('to eat what is foreign'), results in the autophagic-lysosomal destruction of invading pathogens. Several bacterial pathogens including *Mycobacterium tuberculosis* ([@bib36]), group A *Streptococcus* ([@bib81]), *Shigella flexneri* ([@bib85]), *Legionella pneumophila* ([@bib6]), and *Yersinia pestis* ([@bib96]) have been shown to either actively inhibit or be degraded through xenophagy. Subsequently, this process has been demonstrated to be particularly important in restricting bacterial escape and survival. Just as xenophagy restricts certain bacterial pathogens, autophagy may capture replicating viruses or newly assembled virions within their host cells, and eliminate them through sequestration and lysosomal degradation ([@bib48], [@bib61], [@bib134]).

The initial hypothesis that autophagy might function as an antiviral defense mechanism was suggested when the autophagy effector and regulatory protein Beclin-1 was shown to be an antiviral effector in mice infected with the neurotropic Sindbis virus (SINV) ([@bib66]). Over-expression of Beclin-1 protected mice from fatal SINV encephalitis, reducing neuronal apoptosis and decreasing SINV viral replication ([@bib66]). The antiviral and anti-apoptotic effects attributed to Beclin-1 in SINV infection *in vivo* suggested that autophagy may function as a defense against other viral infections. Since these initial observations were first published, further evidence has shown that autophagy may function as a defense against viral infections.

Similar effects to those observed with SINV infection have been demonstrated in HSV-1 encephalitis ([@bib88]). In murine fibroblasts and neurons, mutant HSV-1 deficient in ICP34.5, a viral Beclin-1-interacting protein, but not wild-type virus, induced autophagy upon infection in a PKR-dependent manner ([@bib3], [@bib88], [@bib120], [@bib121]). This viral induction of autophagy resulted in the observed localization and xenophagic degradation of virions within autophagosomes ([@bib2], [@bib3], [@bib121]). However, the exact significance of increased mutant virions within double-membrane vesicles and xenophagy is questionable, since suppression of autophagy through the use of Atg5^−/−^ mouse embryonic fibroblasts (MEFs) did not significantly alter the replication efficiency of either wild-type or ICP34.5 mutant HSV-1 *in vitro* ([@bib3], [@bib44]). In the case of HSV-1, it is thought that while ICP34.5 expression can inhibit autophagy in infected cells, the prevention of PKR-mediated translational arrest, rather than regulation of autophagy, may be the pivotal determinant of HSV-1 replicative efficiency in cell culture ([@bib3]). In contrast to these *in vitro* observations, the suppression of autophagy *in vivo* by ICP34.5 appears to be critical in HSV-1 pathogenesis, since Beclin-1-binding-deficient ICP34.5 mutant viruses are neuroattenuated with regards to lethal encephalitis in mice ([@bib88]). Interestingly, this HSV-1 mutant\'s virulence can be reconstituted if the infection is conducted in mice deficient for the antiviral effector PKR ([@bib88]). The observed discrepancies between *in vitro* and *in vivo* results may be due to cell-type dependent differences, and/or the effects of other HSV-1 proteins on the autophagy pathway ([@bib2]).

The observation that a HSV-1 viral protein that abrogates autophagy is necessary *in vivo* to observe certain pathogenic effects, highlights the potential antiviral function of this pathway. This may be particularly true in the case of neurotropic viruses, since modulation of autophagy has been suggested to influence the development of certain neurological diseases, ([@bib41], [@bib86]). Along these lines, it has been noted that feline, simian, and human immunodeficiency viral infections *in vivo* can indirectly induce deficits in neuronal autophagy, and that this effect may contribute to the neuro-inflammatory pathology observed in these diseases ([@bib4], [@bib148]). Thus, the dysregulation of autophagy by certain neurotropic viruses may not only interfere with their lysosomal clearance, but may also have a significant impact in terms of their pathogenic effect.

One remaining question though is whether xenophagy truly functions as an antiviral effector mechanism, since only HSV-1 viral particles have been observed microscopically within the confines of autophagosomes. Furthermore, this effect may be virus-specific rather than a general defensive mechanism of viral clearance. While it is tempting to speculate that xenophagy, as demonstrated within the field of bacteriology, exists as a general host defense mechanism for the clearance of all intracellular pathogens, including viruses, the limited amount of direct evidence available at this time suggests that caution is warranted. In particular, care should be exercised in differentiating between the incidental inclusion of virion or viral components within autophagosomes due to either their uptake by background or stress-induced activation of this pathway, and enhanced, autophagosome-driven clearance of these materials.

The HSV-1 ICP34.5 protein is known to antagonize PKR by dephosphorylating eIF2α ([@bib37]), and, as discussed above, also blocks the induction of autophagy in a PKR-dependent fashion ([@bib88], [@bib120], [@bib121]). As many viruses employ numerous countermeasures for disrupting the IFN and PKR antiviral systems, these viral disturbances may also have significance in modulating downstream autophagic processes. Indeed, unless a virus can inhibit autophagy it is subject to the effects of immune surveillance which harnesses the autophagy machinery (discussed in [Autophagy may function in security surveillance: a watchdog for foreign molecules](#sec1){ref-type="sec"} section).

Autophagy may function in security surveillance: a watchdog for foreign molecules {#sec1}
---------------------------------------------------------------------------------

In addition to xenophagy, autophagy may function as an antiviral pathway in a less direct fashion, sampling and delivering cytoplasmic material to cellular compartments (endosomes and lysosomes). This process may play a significant role in the activation of innate and adaptive immune responses to foreign pathogens. Research has shown that autophagy is involved in the delivery of various antigens (viral, self, and tumor origin) to MHC class II antigen-presenting molecules, which can in turn lead to the activation of CD4+ T lymphocytes ([@bib63]). As an example, the delivery of Epstein--Barr viral antigens to MHC class II-loading compartment (also known as late endosomes), prior to CD4+ T cell stimulation, has been shown to utilize the autophagy mechanism ([@bib89]). Constitutive autophagy in immune and epithelial cells has also been observed to participate in the delivery of LC3-tagged influenza matrix proteins to MHC class II-associated endosomal compartments, which resulted in enhanced antigen presentation to CD4+ T cells ([@bib107]). Furthermore, the importance of autophagy-mediated class II antigen presentation was recently demonstrated in the regulation of HSV-1 pathogenesis by viral ICP34.5 ([@bib60]). As well, it has been shown that the immunization of mice with influenza A (IFA)-infected cells exhibiting enhanced autophagy facilitates more robust MHC class I antigen presentation to the CD8+ T cells ([@bib127]). This evidence suggests that autophagy may contribute to MHC class I/II-specific viral antigen presentation, aiding the induction of adaptive immune responses. These studies also raise the exciting possibility that it may be feasible to exploit autophagy to deliver viral antigens and enhance MHC class I/II presentation for the development of novel vaccines and adjuvant therapies ([@bib107]).

The autophagy machinery has also been suggested to play a role in innate immunity by delivering PAMPs to their associated PRRs, including the TLRs. TLRs play critical roles in detecting bacterial and viral signatures and in eliciting appropriate host cell defenses such as IFNs and inflammatory cytokines against bacterial and viral infections ([@bib118]). It has been recently shown that the delivery of viral nucleic acids to endosomal TLRs in plasmacytoid dendritic cells (pDCs) can occur through the autophagosomes ([@bib57]). While most TLRs reside on the cell surface, a subset involved in the detection of viral gene products, including TLR3, 7/8, and 9, is located in endosomal compartments and aids in the detection of endocytosed viral material ([@bib10]). Autophagosomes could theoretically facilitate the sequestration, delivery, and detection of cytoplasmic viral nucleic acids, thereby helping to elicit a classical IFN response ([@bib62]). Indeed, autophagy has been shown to mediate ssRNA virus recognition through TLR7 during vesicular stomatitis virus (VSV) and Sendai virus (SENV) infection. It contributes to the production of interferon-α by pDCs *in vitro* and *in vivo* ([@bib57]). Hence, this intrinsic pathway may play an important role in the detection of viral antigens and in the induction of the subsequent IFN response in pDCs.

More recently, evidence supporting the involvement of autophagy in the TLR-related detection of viral PAMPs has increased with the finding that TLRs themselves can induce autophagosome formation. This suggests a potential feedback circuit involving autophagy in the pathogen-triggered immune response. Lipopolysaccharide (LPS)-induced autophagy has been demonstrated in both murine and human macrophages, and requires the TRIF (Toll-interleukin-1 receptor domain-containing adaptor-inducing IFN-β)-dependent TLR4 pathway, whose downstream components include the receptor-interacting protein (RIP1) and the p38 MAPK ([@bib138]). While the physiological importance of this TLR-mediated induction is currently unclear, it suggests that TLR4 can induce autophagy, which may help to limit the spread of pathogenic infections. More importantly, it appears that there is cross-talk between the two pathways and that the autophagic machinery may be regulated by TLRs. TLR3 (dsRNA recognition), TLR7/8 (ssRNA recognition), and TLR9 (recognizes dsDNA with unmethylated CpG motifs) can identify viral signatures ([@bib45]). TLR4 can also recognize mouse mammary tumor virus (MMTV) envelope protein ([@bib99]) and the respiratory syncytial virus (RSV) fusion protein ([@bib54]). In addition, TLR2 recognizes the envelope proteins of HSV-1 ([@bib55]) and human cytomegalovirus ([@bib20]), as well as the measles virus hemagglutinin ([@bib13]). As many of these TLRs share downstream adaptors TRIF and myeloid differentiation primary response gene (88) (MyD88) ([@bib45]), it is possible that apart from TLR4, other TLRs may also trigger autophagy.

On the other hand, autophagy has also been suggested to suppress the innate immune response to VSV infection. The retinoic-acid-inducible gene I (RIG-I)-mediated recognition of VSV in murine fibroblasts is inhibited by over-expression of Atg12--Atg5 ([@bib44]). Furthermore, MEFs deficient in Atg5 or Atg7 are resistant to VSV infection, more sensitive to polyinosinic:polycytidylic acid (poly:IC) treatment, and produce higher type I IFN responses following either treatment ([@bib44], [@bib119]). This evidence suggests that autophagy\'s effects are likely both cell-type- and PRR-dependent, and further demonstrates the intricate nature of the relationship between autophagy and host cell innate immunity.

Viruses can modulate autophagy to determine cell fate by either postponing or hastening cell death {#section0030}
--------------------------------------------------------------------------------------------------

Autophagy is involved with many biological pathways linked to cellular stress, and the signals that drive the activation of autophagy may ultimately decide the fate of the cell. Indeed, it has been suggested that autophagy possesses a dual role in mediating cell survival and cell death. As a survival mechanism, autophagy sustains cell viability during brief periods of cellular stress, either by providing metabolic substrates in times of shortage, or by removing damaged organelles in order to prevent apoptosis. On the other hand, autophagy has also been shown to induce cellular death under certain circumstances, which has been characterized as a form of programmed cell death (type II PCD) that differs from the more classical apoptotic (type I PCD) and necrotic forms of cell death ([@bib65]). Inhibition of autophagy can trigger apoptosis under starvation conditions ([@bib15]), whereas cells deficient in the pro-apoptotic Bax and Bak proteins undergo autophagic cell death upon treatment with strong pharmacological agents such as etoposide ([@bib108]). More importantly, based on autophagy\'s dual nature with regards to cell fate, it has been suggested that this pathway might have important roles in the development of cancer and tumor suppression ([@bib8], [@bib35], [@bib50], [@bib65]) ([@bib17], [@bib29], [@bib70], [@bib79], [@bib102]).

Recent studies indicate that autophagy may function as a pro-survival mechanism during viral infections. Autophagy has been suggested to extend the survival time of human parvovirus B19-infected erythroid cells during viral expansion ([@bib82]). Furthermore, protection against SINV-induced neuronal apoptosis and encephalitis in mice is conferred by concurrent over-expression of Beclin-1, but not anti-apoptotic Bcl-2 ([@bib66]). The hepatitis B virus (HBV)-encoded transcriptional transactivator protein X (HBx) has been shown to up-regulate the expression of Beclin-1 and stimulate autophagy ([@bib122]), an effect that was also observed in HBV-associated hepatocellular carcinomas (HCC) ([@bib114]). Interestingly, HBx has long been suggested to be tumorigenic ([@bib47]), while Beclin-1 is commonly regarded as a haplo-insufficient tumor suppressor gene ([@bib97], [@bib144]). Hence, autophagy could be up-regulated by HBV to prolong cell survival, and this process may help initiate the development of HCC through an as yet uncharacterized mechanism.

As previously indicated, autophagy has been theorized to induce a novel form of programmed cell death, particularly under circumstances when apoptosis is impaired. Hence, while autophagy has been generally characterized as a pro-survival mechanism, certain viruses may counter-intuitively block this process in order to prolong the survival of infected cells. The Kaposi\'s sarcoma-associated herpesvirus (KSHV)-encoded viral Bcl-2 (vBcl-2) protein inhibits autophagy through its interaction with Beclin-1 ([@bib92]) and similar effects have also been observed with the closely related murine γ-herpesvirus-68 (γHV-68)-encoded vBcl-2 molecule M11 ([@bib53], [@bib111]). However, in addition to their effects on autophagy, vBcl-2s from γ-herpesviruses also protect infected cells from apoptosis ([@bib18], [@bib78]). While some authors have suggested that vBcl-2 help γ-herpesviruses escape autophagic degradation ([@bib92]), given the powerful anti-apoptotic role of vBcl-2 it is difficult to gauge the relative importance of these effects. More recently, the KSHV viral FADD-like interleukin-1-β-converting enzyme (FLICE)/caspase-8-inhibitory protein (vFLIP) was shown to suppress autophagy by interfering with the processing of LC3, and that this effect abrogated autophagy-associated cell death in infected cells ([@bib59]).

Interestingly, viral infections have also been documented to trigger autophagy specifically as mechanism of inducing cell death in uninfected bystander cell populations. During HIV infection, expression of HIV envelope glycoproteins (gp120 and gp41, collectively termed "Env") induces autophagy in uninfected bystander CD4+ T lymphocytes, which results in a novel cell death program with characteristics of both type I and type II PCD ([@bib30]). Thus, it has been suggested that this autophagy-mediated phenomenon may be significant in contributing to general CD4+ T cell losses during the course of HIV infections ([@bib30], [@bib31], [@bib64]). Similarly, HIV gp120 could also enhance autophagy in uninfected neuronal cells, leading to neuronal cell death and potentially contributing to HIV-associated dementia ([@bib115]). Interestingly, in plants, autophagy has been shown to protect bystander non-infected cells from cell death induced by Tobacco mosaic virus (TMV) infection ([@bib67]).

The observed differential regulation of autophagy by viral infection in controlling cellular fate provides some indication to the potential complexity of this intrinsic pathway. It is important to note that it is inherently difficult to distinguish between autophagy as a mechanism of virally induced cell death and a cellular response to infection. Furthermore, there is potential that this may be a pathway whose biology is commonly modified in laboratory cancer cell lines used in virology research ([@bib9]). For example, autophagy has been suggested to regulate the death of brain tumor and prostate cancer cell models infected with engineered adenoviruses ([@bib5], [@bib40], [@bib43], [@bib98], [@bib128], [@bib140]), but conflicting results have also suggested that this response may actually be an attempt at survival ([@bib9]). Moreover, as characteristics of both type I and type II PCD are often seen in conjunction, it is often difficult to differentiate whether the observed phenomenon is an executioner mechanism or a futile attempt at cell survival. Nonetheless, from the above discussions it is clear that autophagy can contribute in the regulation of cellular fate, and as such may be specifically regulated by viruses to promote their life cycle.

Discussion {#section0035}
==========

Questions regarding how viral infections interact with, and are impacted by, the autophagy pathway are increasingly gaining prominence within virology. While this relatively new area of research has produced a number of exciting results, limits in our understanding of the mechanism, its regulation, and in the available investigative tools continue to present challenges, as would be expected in any emerging area of research. One complexity for researchers is that the regulation of autophagy is intimately interconnected with cellular growth and survival, as well as numerous cellular stress responses. Hence, considerable caution should be exercised before an effect on viral replication is directly attributed to this pathway. Furthermore, the natural complexity and diversity of viral pathogens and their host cells has resulted in numerous conflicting observations, making it difficult to draw clear and concise conclusions regarding the general role of autophagy in viral infections.

Despite these and other challenges, there is increasing evidence that this ancient cellular process is a significant factor in the fate of numerous different viral infections. During poliovirus infection, autophagy promotes viral replication through its most primitive function: the ability to induce membrane remodeling and vesicle formation. The processes of xenophagy and immune surveillance via cytoplasmic sampling suggest that autophagy may have evolved to act as a defense against intracellular pathogens that viruses must now contend with. Finally, autophagy\'s interconnections with cell death programs ingrain it in processes that ultimately determine cellular fate, suggesting that viruses may modulate it to influence cell survival and ensure their own reproductive advantage. Thus, autophagy may be implicated in the biological pathogenesis and/or replicative success of many viral infections through a wide variety of possible mechanisms, and can exhibit multiple distinct and cell-type-dependent roles in the course of a single viral infection. This is best illustrated in the case of HIV, where the autophagy machinery is: 1) down-regulated in virally-infected CD4+ T cells ([@bib32], [@bib147]), which may constitute a strategy for avoiding autophagosome-mediated degradation and/or endosomal detection in order to enhance virion production; 2) engaged in HIV-infected macrophages to promote virion production ([@bib56]); and 3) activated in bystander neurological and immunological naïve cells to commit cell death by type II PCD, thereby contributing to HIV pathogenesis (CD4+ T cell depletion and neuronal death associated-dementia) ([@bib30]).

The revelation that autophagy can function in immune defense of the host cells, particularly relating to innate immunity, suggests reciprocal regulation (through TLRs and IFN response) aiding in the subsequent development of an adaptive immune response (through enhancement of MHC presentation) to clear pathogens in infected tissues. Further research has the potential to reveal unknown protein interactions and could lead to the development of new pharmacological therapies for treating various virally induced diseases and associated cancers. As new research tools emerge, continuing research will help to clarify the role of autophagy in viral replication, host immune responses, and viral pathogenesis. The intricacies of viral interactions with this ancient and highly conserved pathway strongly suggest that autophagy can function in a myriad of ways, some of which appear contradictory at first glance. Depending upon the circumstances, autophagy can be pro-survival or pro-death, can enhance viral replication or aid in the development of the antiviral response. Autophagy is a double-edged sword that can cut both ways. Clearly a virus would prefer to be on autophagy\'s good side!!

The authors would like to apologize to any investigators whose works were not included during the publication of this work due to space limitation. The authors would also like to thank Dr. Ryan S. Noyce for his critical reading of the manuscript, and Ting-Fen Chin for her technical assistance with [Fig. 1](#fig1){ref-type="fig"}. L.-T. Lin is a recipient of the National CIHR Research Training Program in Hepatitis C (NCRTP-HepC) fellowship. P.W.H. Dawson is a recipient of a Frederick Banting and Charles Best master\'s award from the Canadian Institutes of Health Research (CIHR).
